The following is not meant to be legal advice.
The United States Supreme Court held in Riegel v. Medtronic, Inc. in February 2008 that plaintiffs are barred from alleging common-law claims under state law when challenging the safety and effectiveness of medical devices if the Food and Drug Administration (FDA) has given those devices "premarket approval."
In Riegel, plaintiff brought suit in a New York federal court alleging state-law claims regarding the design, manufacture, and sale of the catheter. A catheter, marketed by Medtronic, was used during the plaintiff's coronary angioplasty surgery. The device was used during the plaintiff's surgery even though the device's labeling and instructions for use said that it should not be used with patients suffering from diffuse or calcified stenoses like the plaintiff was. The plaintiff had suffered a myocardial infarction. The catheter ruptured.

Comment Preview